Evidence map›Paper›PMID 28801676›Full record

ArticleScientific reports2017

Hyaluronic acid coatings as a simple and efficient approach to improve MSC homing toward the site of inflammation.

Bruna Corradetti, Francesca Taraballi, Jonathan O Martinez, Silvia Minardi, Nupur Basu, Guillermo Bauza, Michael Evangelopoulos, Sebastian Powell, Claudia Corbo, Ennio Tasciotti

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07121556 (Randomized Double- Blind Study on the Treatment of Symptomatic Bilateral Knee Osteoarthritis), which is not on this map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07121556 narecruitingnot on this mapstarted 2025, after this paper: background citation

Randomized Double- Blind Study on the Treatment of Symptomatic Bilateral Knee Osteoarthritis: Intra-articular Injection of Autologous Microfragmented Adipose Tissue and Hyaluronic Acid vs Intra Articular Injection of Autologous Microfragmented Adipose Tissue. Double-Blind Randomized Controlled Clinical Trial

TypeinterventionalSponsorIstituto Ortopedico RizzoliRan2025 to 2030Enrolled100ConditionsOsteoarthritis Knees BothArmsMFAT + HA left knee - MFAT + placebo right knee, MFAT + HA right knee - MFAT + placebo left knee
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Bruna CorradettiDepartment of Nanomedicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.ORCID 0000-0002-0345-4847
Francesca TaraballiCenter for Biomimetic Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Jonathan O MartinezCenter for Biomimetic Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.ORCID 0000-0002-0517-366X
Silvia MinardiCenter for Biomimetic Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Nupur BasuCenter for Biomimetic Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Guillermo BauzaCenter for Biomimetic Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Michael EvangelopoulosCenter for Biomimetic Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.ORCID 0000-0002-5300-4289
Sebastian PowellCenter for Biomimetic Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Claudia CorboCenter for Biomimetic Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.ORCID 0000-0001-6468-2571
Ennio TasciottiCenter for Biomimetic Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA. etasciotti@houstonmethodist.org.ORCID 0000-0003-1187-3205
Houston Methodist · USMarche Polytechnic University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A major challenge in regenerative medicine is to improve therapeutic cells' delivery and targeting using an efficient and simple protocol. Mesenchymal stem cells (MSC) are currently employed for the treatment of inflammatory-based diseases, due to their powerful immunosoppressive potential. Here we report a simple and versatile method to transiently overexpress the hyaluronic acid (HA) receptor, CD44, on MSC membranes, to improve their homing potential towards an inflammatory site without affecting their behavior. The effect of HA-coatings on murine MSC was functionally determined both, in vitro and in vivo as a consequence of the transient CD44 overexpression induced by HA. Data obtained from the in vitro migration assay demonstrated a two-fold increase in the migratory potential of HA-treated MSC compared to untreated cells. In an LPS-induced inflamed ear murine model, HA-treated MSC demonstrated a significantly higher inflammatory targeting as observed at 72 hrs as compared to untreated cells. This increased accumulation for HA-treated MSC yielded a substantial reduction in inflammation as demonstrated by the decrease in the expression of pro-inflammatory markers and by the induction of a pro-regenerative environment.

Indexed as

Cell MovementAnimalsCells, CulturedHyaluronan ReceptorsHyaluronic AcidMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMiceMice, Inbred BALB CPrimary Cell CultureHyaluronan ReceptorsHyaluronic Acid

Identifiers

PMID28801676
PMCPMC5554184
OpenAlexW2742359106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.